Yilmaz, OguzSonmez, BingurOzturk, ServetArbath, HarunSener, DenizBaran, TurkerSelcukoglu, Ekrem2024-07-122024-07-1220131301-568010.5606/tgkdc.dergisi.2013.61672-s2.0-84880711125https://dx.doi.org/10.5606/tgkdc.dergisi.2013.6167https://hdl.handle.net/20.500.12415/8528Transcatheter aortic valve implantation (TAVI) has become an alternative treatment modality in patients with severe aortic stenosis who are not candidates for open surgery. We performed two of the initial procedures in our center with the CoreValve (R) Revalving System, which has been recently introduced to the market. In this article, we report the outcomes of this procedure after a nine-month follow-up and discuss the different aspects of the two prostheses commercially available in Turkey.eninfo:eu-repo/semantics/closedAccessAortic stenosispercutaneous cathetertranscatheter aortic valve implantationArticle7723Q376921WOS:000321798900036Q4